Double-blind comparison of astemizole, terfenadine and placebo in hay fever with special regard to onset of action

Details

Serval ID
serval:BIB_E020172C8CEE
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Double-blind comparison of astemizole, terfenadine and placebo in hay fever with special regard to onset of action
Journal
Journal of International Medical Research
Author(s)
Girard  J. P., Sommacal-Schopf  D., Bigliardi  P., Henauer  S. A.
ISSN
0300-0605 (Print)
Publication state
Published
Issued date
1985
Volume
13
Number
2
Pages
102-8
Notes
Clinical Trial
Comparative Study
Journal Article
Randomized Controlled Trial
Abstract
In this double-blind study forty-seven patients with hay fever were treated for 8 days with either terfenadine 60 mg twice a day, astemizole 10 mg once a day or placebo. On the second day of treatment terfenadine was statistically significantly superior to astemizole and placebo according to the ratings of symptomatology, efficacy and individual symptoms. The median onset of symptom alleviation was 3 hours for terfenadine and 2 days for astemizole. On the eighth day both astemizole and terfenadine were statistically significantly more efficacious than placebo, but no significant differences were found between the two drugs. Both drugs were well tolerated.
Keywords
Adult Astemizole Benzhydryl Compounds/administration & dosage/*pharmacology/therapeutic use Benzimidazoles/administration & dosage/*pharmacology/therapeutic use Double-Blind Method Female Humans Male Random Allocation Rhinitis, Allergic, Seasonal/*drug therapy Terfenadine Time Factors
Pubmed
Web of science
Create date
25/01/2008 17:30
Last modification date
20/08/2019 17:04
Usage data